Morgan Stanley’s Bicycle Therapeutics BCYC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.21M Buy
1,037,153
+37,316
+4% +$259K ﹤0.01% 3752
2025
Q1
$8.49M Buy
999,837
+137,700
+16% +$1.17M ﹤0.01% 3490
2024
Q4
$12.1M Sell
862,137
-487,757
-36% -$6.83M ﹤0.01% 3254
2024
Q3
$30.5M Buy
1,349,894
+118,321
+10% +$2.68M ﹤0.01% 2356
2024
Q2
$24.9M Sell
1,231,573
-285,142
-19% -$5.77M ﹤0.01% 2429
2024
Q1
$37.8M Sell
1,516,715
-541,735
-26% -$13.5M ﹤0.01% 2030
2023
Q4
$37.2M Buy
2,058,450
+436,701
+27% +$7.9M ﹤0.01% 2758
2023
Q3
$32.6M Buy
1,621,749
+182,182
+13% +$3.66M ﹤0.01% 1972
2023
Q2
$36.7M Sell
1,439,567
-68,182
-5% -$1.74M ﹤0.01% 1878
2023
Q1
$32.1M Buy
1,507,749
+786,190
+109% +$16.7M ﹤0.01% 1942
2022
Q4
$21.4M Sell
721,559
-138,292
-16% -$4.09M ﹤0.01% 2272
2022
Q3
$20M Buy
859,851
+38,647
+5% +$899K ﹤0.01% 2192
2022
Q2
$13.8M Buy
821,204
+733,287
+834% +$12.3M ﹤0.01% 2703
2022
Q1
$3.86M Sell
87,917
-62,095
-41% -$2.72M ﹤0.01% 3958
2021
Q4
$9.13M Buy
150,012
+5,399
+4% +$329K ﹤0.01% 3041
2021
Q3
$6.02M Buy
144,613
+78,407
+118% +$3.26M ﹤0.01% 3476
2021
Q2
$2.01M Buy
66,206
+63,966
+2,856% +$1.94M ﹤0.01% 4627
2021
Q1
$67K Sell
2,240
-1,232
-35% -$36.9K ﹤0.01% 6209
2020
Q4
$62K Sell
3,472
-517
-13% -$9.23K ﹤0.01% 6087
2020
Q3
$76K Buy
3,989
+515
+15% +$9.81K ﹤0.01% 5546
2020
Q2
$55K Buy
3,474
+219
+7% +$3.47K ﹤0.01% 5645
2020
Q1
$44K Buy
3,255
+3,245
+32,450% +$43.9K ﹤0.01% 5509
2019
Q4
$0 Buy
+10
New ﹤0.01% 6644